Filtered By:
Cancer: Lymphoma
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 96936 results found since Jan 2013.
Scurvy, abnormal MRI, and gelatinous bone marrow in an adolescent with avoidant restrictive food intake disorder
ConclusionsAlthough this patient had common manifestations of scurvy, including perifollicular petechial hemorrhagic rash, joint effusions, anemia, and recurrent fevers, she still underwent an extensive workup. Clinicians should be aware that scurvy can present with multiple symptoms that mimic infectious, rheumatic, oncologic and hematological disease. Clinicians should have a high index of suspicion for scurvy in patients with malnutrition and eating disorders.
Source: Journal of Eating Disorders - March 20, 2023 Category: Eating Disorders & Weight Management Source Type: research
Types of Colon Cancer - Learn about Each Type...
Adenocarcinoma is the most common type of colon cancer but there are many other forms as well. Examples include leiomyosarcoma, lymphoma, melanoma, and neuroendocrine tumors. Here, you can learn more about each type of colon cancer.
Source: About.com Colon Cancer - July 11, 2013 Category: Cancer & Oncology Authors: coloncancer.guide at about.com Tags: health Source Type: news
Learn About Each Type of Colon Cancer
Adenocarcinoma is the most common type of colon cancer but there are many other forms as well. Examples include leiomyosarcoma, lymphoma, melanoma, and neuroendocrine tumors. Here, you can learn more about each type of colon cancer.
Source: About.com Colon Cancer - March 1, 2016 Category: Cancer & Oncology Authors: coloncancer.guide at about.com Tags: health Source Type: news
What is Lymphoma of the Colon and Rectum?
Lymphoma of the colon and rectum is a less common form of colorectal cancer. Learn about what went wrong with the lymphatic system in this condition.
Source: About.com Colon Cancer - December 6, 2015 Category: Cancer & Oncology Authors: coloncancer.guide at about.com Tags: health Source Type: news
FDA Approves Gene Therapy Tested In Boston To Treat Adults With Lymphoma
TRENTON, N.J. (CBS/AP) — U.S. regulators on Wednesday approved a second gene therapy for a blood cancer, a one-time, custom-made treatment for aggressive lymphoma in adults.
The Food and Drug Administration allowed sales of the treatment from Kite Pharma. It uses the same technology, called CAR-T, as the first gene therapy approved in the U.S. in August, a treatment for childhood leukemia from Novartis Pharmaceuticals.
That Novartis treatment was tested in Boston. In those tests, Dana Farber and Brigham and Women’s Hospital cancer researchers found that 80 percent of lymphoma patients who underwent the treatment we...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - October 19, 2017 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Healthwatch Local News blood cancer Brigham and Women's Hospital Dana Farber FDA Gene Therapy Novartis Pharmaceuticals Source Type: news
Janssen to Highlight Latest Scientific Advances in Hematologic Diseases at ASH 2022 with Clinical and Real-World Data Across Innovative Pipeline and Distinguished Portfolio
RARITAN, N.J., November 3, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson are committed to redefining treatment outcomes in the hematology setting and today announced that abstracts from more than 50 company-sponsored studies, plus more than 20 investigator-initiated studies, will be presented at the American Society of Hematology (ASH) Annual Meeting in New Orleans from December 10-13, 2022. Janssen’s commitment to advancing an innovative portfolio of therapies for healthcare professionals and patients is evidenced through more than 70 presentations that span clinical studies and r...
Source: Johnson and Johnson - November 3, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
Lymphoma of the Colon and Rectum
Lymphoma of the colon and rectum accounts for less than half a percent of all colorectal cancers. A lymphoma is like a city whose mayor has gone mad and designs a machine to crank out drones who have one purpose: to make sure he stays in office.
Source: About.com Colon Cancer - June 5, 2013 Category: Cancer & Oncology Authors: coloncancer.guide at about.com Tags: health Source Type: news
Proteasomal cysteine deubiquitinase inhibitor b-AP15 suppresses migration and induces apoptosis in diffuse large B cell lymphoma
The first line therapy for patients with diffuse large B cell (DLBCL) is R-CHOP. About half of DLBCL patients are either refractory to, or will relapse, after the treatment. Therefore, identifying novel drug t...
Source: Journal of Experimental and Clinical Cancer Research - November 6, 2019 Category: Cancer & Oncology Authors: Liling Jiang, Yuening Sun, Jinxiang Wang, Qingyan He, Xinmei Chen, Xiaoying Lan, Jinghong Chen, Q. Ping Dou, Xianping Shi and Jinbao Liu Tags: Research Source Type: research
Multiple Myeloma and the Bone Marrow Niche
Multiple Myeloma (MM) is a disease of plasma cells with specific localization in the bone marrow. Recent studies have shown that MM is consistently preceded by MGUS. This has given rise to the concept of a myeloma precursor disease and raised questions about the biologic events leading to progression of these precursor states to symptomatic MM. The genomic complexity in MM was recently corroborated next generation sequencing that provided resolution pictures of the genetic changes in cancer cells and heterogeneity in tumors where tumor progression proceeds in a branching rather than in a linear manner, leading to substanti...
Source: Clinical Lymphoma, Myeloma and Leukemia - September 1, 2015 Category: Hematology Authors: I.M. Ghobrial Source Type: research
Targeting BCL2 with BH3 mimetics: Basic Science and Clinical Application of Venetoclax in CLL and related B cell malignancies.
This article is protected by copyright. All rights reserved.
PMID: 27806433 [PubMed - as supplied by publisher]
Source: Clinical Pharmacology and Therapeutics - November 1, 2016 Category: Drugs & Pharmacology Authors: Roberts AW, Huang DC Tags: Clin Pharmacol Ther Source Type: research
Mortality of lymphoma and myeloma in China, 2004 –2017: an observational study
There is a dearth of accurate information about patterns of mortality of lymphoid neoplasms and temporal trends in China. In this nationwide mortality study, we aimed to assess the mortality of lymphoma and my...
Source: Journal of Hematology and Oncology - March 4, 2019 Category: Hematology Authors: Weiping Liu, Jiangmei Liu, Yuqin Song, Xiaopei Wang, Maigeng Zhou, Lijun Wang, Jun Ma and Jun Zhu Tags: Research Source Type: research
Clinicopathological and prognostic features of hepatitis B virus-associated diffuse large B-cell lymphoma: a single-center retrospective study in China
While the epidemiologic association between hepatitis B virus (HBV) infection and diffuse large B-cell lymphoma (DLBCL) is established, little is known about the pathological characteristics and outcome of DLB...
Source: Infectious Agents and Cancer - August 17, 2021 Category: Cancer & Oncology Authors: Dao-guang Chen, Gang Chen, Chang Wang, Long-feng Ke, Hui Wu, Hong-ming He, Yu Yang and Yan-ping Chen Tags: Research Article Source Type: research
Facilitating direct patient access to safety information about their breast implant: A Patient Access Tool sourced by the Dutch Breast Implant Registry
Breast implants are widely used medical devices with 1 in 30 women (3.3%) carrying them.1 The high prevalence of breast implants explains why lay-media reporting on health risks, often oversimplified and not always scientifically proven, can incite public turmoil, causing significant anxiety among patients. Recently this was demonstrated with the FDA and ANSM public hearings on breast implant-associated anaplastic large-cell lymphoma and Breast Implant Illness, and the media coverage following this.
Source: Journal of Plastic, Reconstructive and Aesthetic Surgery - February 28, 2023 Category: Cosmetic Surgery Authors: JX Harmeling, TA Bruins, BE Becherer, MJ Hoornweg, M Harmsen, MAM Mureau, HA Rakhorst Tags: Correspondence and Communications Source Type: research
Angioimmunoblastic T-cell Lymphoma Mimicking Systemic Lupus Erythematosus: A Case Report and Literature Review
CONCLUSION: Patients with AITL generally have a poor prognosis. Rarely do reported cases show AITL mimicking SLE. AITL should be considered during clinical practice to prevent missed diagnoses or misdiagnoses.PMID:37708543
Source: Alternative Therapies in Health and Medicine - September 14, 2023 Category: Complementary Medicine Authors: Yanni Wang Zhenglun Pan Source Type: research
